Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rizatriptan (MK0462) for Acute Migraine and Recurrence
NCT00897949Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Mar 1995
- Primary completion
- Jan 1996
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, triple-blind trial of rizatriptan in migraine (3 arms), sponsored by Organon & Co. Primary endpoint: Pain Relief at 2 Hours After the Initial Dose of Test Drug. Started Mar 1995; status: completed.
02
Drugs
rizatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00897949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00897949.